Kineta, Inc

Kineta, Inc

Kineta, Inc

Kineta is a nationally-recognized biotechnology company developing novel autoimmune, antiviral and chronic pain therapeutics
Type
B2c
Founded
2007
Raised
$11.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$5,000,000
Venture capital - 2020
Schlaepfer Family Foundation
Undisclosed amount
Undisclosed funding - 2016
Team Size
10+
Employees
$5,000,000 Venture capital
the home of AI info

Kineta Closes Investment Round to Advance Early Preclinical Development of Immuno-oncology …

the home of AI info

Kineta Invited to Participate at the BIO CEO & Investor Conference

the home of AI info

Kineta Invited to Participate at the BIO CEO & Investor Conference

FinSMEs

Kineta Raises $1.8M in Funding

GeekWire

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

GeekWire

Kineta signs multi-million dollar collaboration with Genentech to develop non-opioid pain medication

Health
Undisclosed funding
GeekWire

This Seattle biotech startup just secured funding to tackle the Zika virus

Health
$1,500,000 Grant
yahoo , GeekWire , sec

Kineta Secures NIAID Funding to Expand Testing of Immune Modulators

Health
$4,000,000 Grant
GeekWire

Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others

Health